Plus500 does not provide CFD services to residents of the United States. Visit our U.S. website at us.plus500.com.

TG Therapeutics TGTX

High: Low:

TG Therapeutics Inc. Company that develops treatments for patients wit B-cell malignancies and autoimmune diseases. Based in New York. Yahoo! Finance

TG Therapeutics (TGTX) Price Chart

Traders' Sentiments

Info

TG Therapeutics Inc. Company that develops treatments for patients wit B-cell malignancies and autoimmune diseases. Based in New York. Yahoo! Finance

Spread 0.12 Spread (%) 0.72%
Overnight funding - Buy -0.06144% Overnight funding - Sell -0.0264%
Initial margin 20.00% Maintenance margin 10.00%
Leverage 1:5 Expires daily No

Related Instruments

What is TG Therapeutics?

TG Therapeutics (NASDAQ: TGTX) is an American biopharmaceutical company focused on leveraging leverage scientific advances in B-cell biology to develop novel patient treatments. The FDA approved its BRIUMVI drug for multiple sclerosis. The TGTX share price can depend on clinical trials, regulatory approvals, competition, healthcare policies, and investor sentiment. Partnerships, licensing agreements, and mergers and acquisitions also impact investor confidence and stock performance.

How do I trade TG Therapeutics?

Start trading TG Therapeutics in 5 steps:
  1. Choose how you want to trade TG Therapeutics
  2. Learn about the TG Therapeutics Stock CFD
  3. Open and verify your Plus500 account
  4. Plan your TG Therapeutics trading strategy
  5. Start trading!

Related News & Market Insights

Why Plus500?

Protected & secure

Your data is safe and your funds are kept in segregated bank accounts, in accordance with regulatory requirements.

Professional support

Get around-the-clock dedicated customer service in multiple languages.

Regulated

Licensed and regulated by a variety of global leading regulators. Learn more.

Recognised

Plus500 Ltd is a FTSE 250 company listed on the London Stock Exchange’s Main Market for Listed Companies.
Need Help?
24/7 Support